Table of Content

1. Executive Summary
   1.1. Global Iron Deficiency Anemia Therapy Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 – 2031, US$ Bn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Industry Developments and Key Market Events
   1.6. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Meat Substitutes Market: Value Chain
       2.3.1. List of key players
       2.3.2. List of key distributors
   2.4. Forecast Factors – Relevance and Impact
   2.5. Covid-19 Impact Assessment
   2.6. PESTLE Analysis
   2.7. Porter Five Force’s Analysis
3. Key Regulations/ Standards
4. Price Trend Analysis, 2019 – 2031
   4.1. Key Factors Impacting Prices
   4.2. Prices by Source
5. Global Iron Deficiency Anemia Therapy Market Outlook: Historical (2019 – 2023) and Forecast (2024 – 2031)
   5.1. Market Size (US$ Bn) Analysis and Forecast
       5.1.1. Historical Market Size Analysis, 2018–2022
       5.1.2. Current Market Size Forecast, 2023–2031
   5.2. Global Iron Deficiency Anemia Therapy Market Outlook: Product Type
       5.2.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019 – 2023
       5.2.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024 – 2031
           5.2.2.1. Ferrous Sulphate
           5.2.2.2. Ferrous Gluconate
           5.2.2.3. Ferrous Fumarate
           5.2.2.4. Ferric Hydroxide
           5.2.2.5. Others
       5.2.3. Market Attractiveness Analysis: Product Type
   5.3. Global Iron Deficiency Anemia Therapy Market Outlook: Therapy Areas
       5.3.1. Historical Market Size (US$ Bn) Analysis By Therapy Areas, 2019 – 2023
       5.3.2. Current Market Size (US$ Bn) Forecast By Therapy Areas, 2024 – 2031
           5.3.2.1. Inflammatory Bowel Disease
           5.3.2.2. Renal
           5.3.2.3. Obstetrics and gynaecology
           5.3.2.4. Congestive heart failure (CHF)
           5.3.2.5. Oncology
           5.3.2.6. Other therapy areas
       5.3.3. Market Attractiveness Analysis: Therapy Areas
   5.4. Global Iron Deficiency Anemia Therapy Market Outlook: Age Group
       5.4.1. Historical Market Size (US$ Bn) Analysis By Category, 2019 – 2023
       5.4.2. Current Market Size (US$ Bn) Forecast By Category, 2024 – 2031
           5.4.2.1. Adults
           5.4.2.2. Paediatric
           5.4.2.3. Geriatric
       5.4.3. Market Attractiveness Analysis: Age Group
   5.5. Global Iron Deficiency Anemia Therapy Market Outlook: By Formulation
       5.5.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019 – 2023
       5.5.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024 – 2031
           5.5.2.1. Tablets
           5.5.2.2. Capsules
           5.5.2.3. Liquids
           5.5.2.4. Others
       5.5.3. Market Attractiveness Analysis: Formulation
   5.6. Global Iron Deficiency Anemia Therapy Market Outlook: By Distribution Channel
       5.6.1. Historical Market Size (US$ Bn) Analysis By Distribution Channel, 2019 - 2023
       5.6.2. Current Market Size (US$ Bn) Forecast By Distribution Channel, 2024 - 2031
           5.6.2.1. Hospital Pharmacies
           5.6.2.2. Retail Pharmacies
           5.6.2.3. Online Pharmacies
       5.6.3. Market Attractiveness Analysis: Distribution Channel
6. Global Iron Deficiency Anemia Therapy Market Outlook: Region
   6.1. Historical Market Size (US$ Bn) Analysis By Region, 2019 – 2023
   6.2. Current Market Size (US$ Bn) Forecast By Region, 2024 – 2031
       6.2.1. North America
       6.2.2. Europe
       6.2.3. East Asia
       6.2.4. South Asia and Oceania
       6.2.5. Latin America
       6.2.6. Middle East & Africa
   6.3. Market Attractiveness Analysis: Region
7. North America Iron Deficiency Anemia Therapy Market Outlook: Historical (2019 – 2023) and Forecast (2024 – 2031)
   7.1. Historical Market Size (US$ Bn) Analysis By Market, 2019 – 2023
       7.1.1. By Country
       7.1.2. By Product Type
       7.1.3. By Therapy Areas
       7.1.4. Age Group
       7.1.5. Formulation
       7.1.6. By Distribution Channel
   7.2. Current Market Size (US$ Bn) Forecast By Country, 2024 – 2031
       7.2.1. U.S.
       7.2.2. Canada
   7.3. North America Iron Deficiency Anemia Therapy Market Outlook: Product Type
       7.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019 – 2023
       7.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024 – 2031
           7.3.2.1. Ferrous Sulphate
           7.3.2.2. Ferrous Gluconate
           7.3.2.3. Ferrous Fumarate
           7.3.2.4. Ferric Hydroxide
           7.3.2.5. Others
       7.3.3. Market Attractiveness Analysis: Product Type
   7.4. North America Iron Deficiency Anemia Therapy Market Outlook: Therapy Areas
       7.4.1. Historical Market Size (US$ Bn) Analysis By Therapy Areas, 2019 – 2023
       7.4.2. Current Market Size (US$ Bn) Forecast By Therapy Areas, 2024 – 2031
           7.4.2.1. Inflammatory Bowel Disease
           7.4.2.2. Renal
           7.4.2.3. Obstetrics and gynaecology
           7.4.2.4. Congestive heart failure (CHF)
           7.4.2.5. Oncology
           7.4.2.6. Other therapy areas
       7.4.3. Market Attractiveness Analysis: Therapy Areas
   7.5. North America Iron Deficiency Anemia Therapy Market Outlook: Age Group
       7.5.1. Historical Market Size (US$ Bn) Analysis By Category, 2019 – 2023
       7.5.2. Current Market Size (US$ Bn) Forecast By Category, 2024 – 2031
           7.5.2.1. Adults
           7.5.2.2. Paediatric
           7.5.2.3. Geriatric
       7.5.3. Market Attractiveness Analysis: Age Group
   7.6. North America Iron Deficiency Anemia Therapy Market Outlook: By Formulation
       7.6.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019 – 2023
       7.6.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024 – 2031
           7.6.2.1. Tablets
           7.6.2.2. Capsules
           7.6.2.3. Liquids
           7.6.2.4. Others
       7.6.3. Market Attractiveness Analysis: Formulation
   7.7. North America Iron Deficiency Anemia Therapy Market Outlook: By Distribution Channel
       7.7.1. Historical Market Size (US$ Bn) Analysis By Distribution Channel, 2019 - 2023
       7.7.2. Current Market Size (US$ Bn) Forecast By Distribution Channel, 2024 - 2031
           7.7.2.1. Hospital Pharmacies
           7.7.2.2. Retail Pharmacies
           7.7.2.3. Online Pharmacies
       7.7.3. Market Attractiveness Analysis: Distribution Channel
   7.8. Market Attractiveness Analysis
8. Europe Iron Deficiency Anemia Therapy Market Outlook: Historical (2019 – 2023) and Forecast (2024 – 2031)
   8.1. Historical Market Size (US$ Bn) Analysis By Market, 2019 – 2023
       8.1.1. By Country
       8.1.2. By Product Type
       8.1.3. By Therapy Areas
       8.1.4. By Age Group
       8.1.5. By Formulation
       8.1.6. By Distribution Channel
   8.2. Current Market Size (US$ Bn) Forecast By Country, 2024 – 2031
       8.2.1. Germany
       8.2.2. France
       8.2.3. U.K.
       8.2.4. Italy
       8.2.5. Spain
       8.2.6. Russia
   8.3. Europe Iron Deficiency Anemia Therapy Market Outlook: Product Type
       8.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019 – 2023
       8.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024 – 2031
           8.3.2.1. Ferrous Sulphate
           8.3.2.2. Ferrous Gluconate
           8.3.2.3. Ferrous Fumarate
           8.3.2.4. Ferric Hydroxide
           8.3.2.5. Others
       8.3.3. Market Attractiveness Analysis: Product Type
   8.4. Europe Iron Deficiency Anemia Therapy Market Outlook: Therapy Areas
       8.4.1. Historical Market Size (US$ Bn) Analysis By Therapy Areas, 2019 – 2023
       8.4.2. Current Market Size (US$ Bn) Forecast By Therapy Areas, 2024 – 2031
           8.4.2.1. Inflammatory Bowel Disease
           8.4.2.2. Renal
           8.4.2.3. Obstetrics and gynaecology
           8.4.2.4. Congestive heart failure (CHF)
           8.4.2.5. Oncology
           8.4.2.6. Other therapy areas
       8.4.3. Market Attractiveness Analysis: Therapy Areas
   8.5. Europe Iron Deficiency Anemia Therapy Market Outlook: Age Group
       8.5.1. Historical Market Size (US$ Bn) Analysis By Category, 2019 – 2023
       8.5.2. Current Market Size (US$ Bn) Forecast By Category, 2024 – 2031
           8.5.2.1. Adults
           8.5.2.2. Paediatric
           8.5.2.3. Geriatric
       8.5.3. Market Attractiveness Analysis: Age Group
   8.6. Europe Iron Deficiency Anemia Therapy Market Outlook: By Formulation
       8.6.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019 – 2023
       8.6.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024 – 2031
           8.6.2.1. Tablets
           8.6.2.2. Capsules
           8.6.2.3. Liquids
           8.6.2.4. Others
       8.6.3. Market Attractiveness Analysis: Formulation
   8.7. Europe Iron Deficiency Anemia Therapy Market Outlook: By Distribution Channel
       8.7.1. Historical Market Size (US$ Bn) Analysis By Distribution Channel, 2019 - 2023
       8.7.2. Current Market Size (US$ Bn) Forecast By Distribution Channel, 2024 - 2031
           8.7.2.1. Hospital Pharmacies
           8.7.2.2. Retail Pharmacies
           8.7.2.3. Online Pharmacies
       8.7.3. Market Attractiveness Analysis: Distribution Channel
   8.8. Market Attractiveness Analysis
9. East Asia Iron Deficiency Anemia Therapy Outlook: Historical (2019 – 2023) and Forecast (2024 – 2031)
   9.1. Historical Market Size (US$ Bn) Analysis By Market, 2019 – 2023
       9.1.1. By Country
       9.1.2. By Product Type
       9.1.3. By Therapy Areas
       9.1.4. By Age Group
       9.1.5. By Formulation
       9.1.6. By Distribution Channel
   9.2. Current Market Size (US$ Bn) Forecast By Country, 2024 – 2031
       9.2.1. China
       9.2.2. Japan
       9.2.3. South Korea
   9.3. East Asia Iron Deficiency Anemia Therapy Market Outlook: Product Type
       9.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019 – 2023
       9.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024 – 2031
           9.3.2.1. Ferrous Sulphate
           9.3.2.2. Ferrous Gluconate
           9.3.2.3. Ferrous Fumarate
           9.3.2.4. Ferric Hydroxide
           9.3.2.5. Others
       9.3.3. Market Attractiveness Analysis: Product Type
   9.4. East Asia Iron Deficiency Anemia Therapy Market Outlook: Therapy Areas
       9.4.1. Historical Market Size (US$ Bn) Analysis By Therapy Areas, 2019 – 2023
       9.4.2. Current Market Size (US$ Bn) Forecast By Therapy Areas, 2024 – 2031
           9.4.2.1. Inflammatory Bowel Disease
           9.4.2.2. Renal
           9.4.2.3. Obstetrics and gynaecology
           9.4.2.4. Congestive heart failure (CHF)
           9.4.2.5. Oncology
           9.4.2.6. Other therapy areas
       9.4.3. Market Attractiveness Analysis: Therapy Areas
   9.5. East Asia Iron Deficiency Anemia Therapy Market Outlook: Age Group
       9.5.1. Historical Market Size (US$ Bn) Analysis By Category, 2019 – 2023
       9.5.2. Current Market Size (US$ Bn) Forecast By Category, 2024 – 2031
           9.5.2.1. Adults
           9.5.2.2. Paediatric
           9.5.2.3. Geriatric
       9.5.3. Market Attractiveness Analysis: Age Group
   9.6. East Asia Iron Deficiency Anemia Therapy Market Outlook: By Formulation
       9.6.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019 – 2023
       9.6.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024 – 2031
           9.6.2.1. Tablets
           9.6.2.2. Capsules
           9.6.2.3. Liquids
           9.6.2.4. Others
       9.6.3. Market Attractiveness Analysis: Formulation
   9.7. East Asia Iron Deficiency Anemia Therapy Market Outlook: By Distribution Channel
       9.7.1. Historical Market Size (US$ Bn) Analysis By Distribution Channel, 2019 - 2023
       9.7.2. Current Market Size (US$ Bn) Forecast By Distribution Channel, 2024 - 2031
           9.7.2.1. Hospital Pharmacies
           9.7.2.2. Retail Pharmacies
           9.7.2.3. Online Pharmacies
       9.7.3. Market Attractiveness Analysis: Distribution Channel
   9.8. Market Attractiveness Analysis
10. South Asia & Oceania Iron Deficiency Anemia Therapy Market Outlook: Historical (2019 – 2023) and Forecast (2024 – 2031)
   10.1. Historical Market Size (US$ Bn) Analysis By Market, 2019 – 2023
       10.1.1. By Country
       10.1.2. By Product Type
       10.1.3. By Therapy Areas
       10.1.4. By Age Group
       10.1.5. By Formulation
       10.1.6. By Distribution Channel
   10.2. Current Market Size (US$ Bn) Forecast By Country, 2024 – 2031
       10.2.1. India
       10.2.2. Southeast Asia
       10.2.3. ANZ
       10.2.4. Rest of South Asia & Oceania
   10.3. South Asia & Oceania Iron Deficiency Anemia Therapy Market Outlook: Product Type
       10.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019 – 2023
       10.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024 – 2031
           10.3.2.1. Ferrous Sulphate
           10.3.2.2. Ferrous Gluconate
           10.3.2.3. Ferrous Fumarate
           10.3.2.4. Ferric Hydroxide
           10.3.2.5. Others
       10.3.3. Market Attractiveness Analysis: Product Type
   10.4. South Asia & Oceania Iron Deficiency Anemia Therapy Market Outlook: Therapy Areas
       10.4.1. Historical Market Size (US$ Bn) Analysis By Therapy Areas, 2019 – 2023
       10.4.2. Current Market Size (US$ Bn) Forecast By Therapy Areas, 2024 – 2031
           10.4.2.1. Inflammatory Bowel Disease
           10.4.2.2. Renal
           10.4.2.3. Obstetrics and gynaecology
           10.4.2.4. Congestive heart failure (CHF)
           10.4.2.5. Oncology
           10.4.2.6. Other therapy areas
       10.4.3. Market Attractiveness Analysis: Therapy Areas
   10.5. South Asia & Oceania Iron Deficiency Anemia Therapy Market Outlook: Age Group
       10.5.1. Historical Market Size (US$ Bn) Analysis By Category, 2019 – 2023
       10.5.2. Current Market Size (US$ Bn) Forecast By Category, 2024 – 2031
           10.5.2.1. Adults
           10.5.2.2. Paediatric
           10.5.2.3. Geriatric
       10.5.3. Market Attractiveness Analysis: Age Group
   10.6. South Asia & Oceania Iron Deficiency Anemia Therapy Market Outlook: By Formulation
       10.6.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019 – 2023
       10.6.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024 – 2031
           10.6.2.1. Tablets
           10.6.2.2. Capsules
           10.6.2.3. Liquids
           10.6.2.4. Others
       10.6.3. Market Attractiveness Analysis: Formulation
   10.7. South Asia & Oceania Iron Deficiency Anemia Therapy Market Outlook: By Distribution Channel
       10.7.1. Historical Market Size (US$ Bn) Analysis By Distribution Channel, 2019 - 2023
       10.7.2. Current Market Size (US$ Bn) Forecast By Distribution Channel, 2024 - 2031
           10.7.2.1. Hospital Pharmacies
           10.7.2.2. Retail Pharmacies
           10.7.2.3. Online Pharmacies
       10.7.3. Market Attractiveness Analysis: Distribution Channel
   10.8. Market Attractiveness Analysis
11. Latin America Iron Deficiency Anemia Therapy Market Outlook: Historical (2019 – 2023) and Forecast (2024 – 2031)
   11.1. Historical Market Size (US$ Bn) Analysis By Market, 2019 – 2023
       11.1.1. By Country
       11.1.2. By Product Type
       11.1.3. By Therapy Areas
       11.1.4. By Age Group
       11.1.5. By Formulation
       11.1.6. By Distribution Channel
   11.2. Current Market Size (US$ Bn) Forecast By Country, 2024 – 2031
       11.2.1. Brazil
       11.2.2. Mexico
   11.3. Latin America Iron Deficiency Anemia Therapy Market Outlook: Product Type
       11.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019 – 2023
       11.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024 – 2031
           11.3.2.1. Ferrous Sulphate
           11.3.2.2. Ferrous Gluconate
           11.3.2.3. Ferrous Fumarate
           11.3.2.4. Ferric Hydroxide
           11.3.2.5. Others
       11.3.3. Market Attractiveness Analysis: Product Type
   11.4. Latin America Iron Deficiency Anemia Therapy Market Outlook: Therapy Areas
       11.4.1. Historical Market Size (US$ Bn) Analysis By Therapy Areas, 2019 – 2023
       11.4.2. Current Market Size (US$ Bn) Forecast By Therapy Areas, 2024 – 2031
           11.4.2.1. Inflammatory Bowel Disease
           11.4.2.2. Renal
           11.4.2.3. Obstetrics and gynaecology
           11.4.2.4. Congestive heart failure (CHF)
           11.4.2.5. Oncology
           11.4.2.6. Other therapy areas
       11.4.3. Market Attractiveness Analysis: Therapy Areas
   11.5. Latin America Iron Deficiency Anemia Therapy Market Outlook: Age Group
       11.5.1. Historical Market Size (US$ Bn) Analysis By Category, 2019 – 2023
       11.5.2. Current Market Size (US$ Bn) Forecast By Category, 2024 – 2031
           11.5.2.1. Adults
           11.5.2.2. Paediatric
           11.5.2.3. Geriatric
       11.5.3. Market Attractiveness Analysis: Age Group
   11.6. Latin America Iron Deficiency Anemia Therapy Market Outlook: By Formulation
       11.6.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019 – 2023
       11.6.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024 – 2031
           11.6.2.1. Tablets
           11.6.2.2. Capsules
           11.6.2.3. Liquids
           11.6.2.4. Others
       11.6.3. Market Attractiveness Analysis: Formulation
   11.7. Latin America Iron Deficiency Anemia Therapy Market Outlook: By Distribution Channel
       11.7.1. Historical Market Size (US$ Bn) Analysis By Distribution Channel, 2019 - 2023
       11.7.2. Current Market Size (US$ Bn) Forecast By Distribution Channel, 2024 - 2031
           11.7.2.1. Hospital Pharmacies
           11.7.2.2. Retail Pharmacies
           11.7.2.3. Online Pharmacies
       11.7.3. Market Attractiveness Analysis: Distribution Channel
   11.8. Market Attractiveness Analysis
12. Middle East & Africa Iron Deficiency Anemia Therapy Market Outlook: Historical (2019 – 2023) and Forecast (2024 – 2031)
   12.1. Historical Market Size (US$ Bn) Analysis By Market, 2019 – 2023
       12.1.1. By Country
       12.1.2. By Product Type
       12.1.3. By Therapy Areas
       12.1.4. By Age Group
       12.1.5. By Formulation
       12.1.6. By Distribution Channel
   12.2. Current Market Size (US$ Bn) Forecast By Country, 2024 – 2031
       12.2.1. GCC
       12.2.2. South Africa
       12.2.3. Northern Africa
   12.3. Middle East & Africa Iron Deficiency Anemia Therapy Market Outlook: Product Type
       12.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019 – 2023
       12.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024 – 2031
           12.3.2.1. Ferrous Sulphate
           12.3.2.2. Ferrous Gluconate
           12.3.2.3. Ferrous Fumarate
           12.3.2.4. Ferric Hydroxide
           12.3.2.5. Others
       12.3.3. Market Attractiveness Analysis: Product Type
   12.4. Middle East & Africa Iron Deficiency Anemia Therapy Market Outlook: Therapy Areas
       12.4.1. Historical Market Size (US$ Bn) Analysis By Therapy Areas, 2019 – 2023
       12.4.2. Current Market Size (US$ Bn) Forecast By Therapy Areas, 2024 – 2031
           12.4.2.1. Inflammatory Bowel Disease
           12.4.2.2. Renal
           12.4.2.3. Obstetrics and gynaecology
           12.4.2.4. Congestive heart failure (CHF)
           12.4.2.5. Oncology
           12.4.2.6. Other therapy areas
       12.4.3. Market Attractiveness Analysis: Therapy Areas
   12.5. Middle East & Africa Iron Deficiency Anemia Therapy Market Outlook: Age Group
       12.5.1. Historical Market Size (US$ Bn) Analysis By Category, 2019 – 2023
       12.5.2. Current Market Size (US$ Bn) Forecast By Category, 2024 – 2031
           12.5.2.1. Adults
           12.5.2.2. Paediatric
           12.5.2.3. Geriatric
       12.5.3. Market Attractiveness Analysis: Age Group
   12.6. Middle East & Africa Iron Deficiency Anemia Therapy Market Outlook: By Formulation
       12.6.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019 – 2023
       12.6.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024 – 2031
           12.6.2.1. Tablets
           12.6.2.2. Capsules
           12.6.2.3. Liquids
           12.6.2.4. Others
       12.6.3. Market Attractiveness Analysis: Formulation
   12.7. Middle East & Africa Iron Deficiency Anemia Therapy Market Outlook: By Distribution Channel
       12.7.1. Historical Market Size (US$ Bn) Analysis By Distribution Channel, 2019 - 2023
       12.7.2. Current Market Size (US$ Bn) Forecast By Distribution Channel, 2024 - 2031
           12.7.2.1. Hospital Pharmacies
           12.7.2.2. Retail Pharmacies
           12.7.2.3. Online Pharmacies
       12.7.3. Market Attractiveness Analysis: Distribution Channel
   12.8. Market Attractiveness Analysis
13. Competition Landscape
   13.1. Market Share Analysis, 2023
   13.2. Market Structure
       13.2.1. Competition Intensity Mapping By Market
       13.2.2. Competition Dashboard
       13.2.3. Tier Structure Analysis
       13.2.4. Regional Presence Analysis
   13.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
       13.3.1. Akebia Therapeutics Inc.
           13.3.1.1. Overview
           13.3.1.2. Segments and Products
           13.3.1.3. Key Financials
           13.3.1.4. Market Developments
           13.3.1.5. Market Strategy
       13.3.2. Bayer AG
       13.3.3. Pharmacosmos A/S
       13.3.4. Sanofi
       13.3.5. Johnson & Johnson Services, Inc.
       13.3.6. CSL Vifor
       13.3.7. Abbvie Inc. (Allergan)
       13.3.8. Novartis AG
       13.3.9. Teoxane
       13.3.10. GSK plc.
       13.3.11. AdvaCare Pharma
       13.3.12. Apotex Inc.
       13.3.13. Covis Pharma GmbH
14. Appendix
   14.1. Research Methodology
   14.2. Research Assumptions
   14.3. Acronyms and Abbreviations